Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's Drug Advertising Oversight Gets A Promotion From A Division To An Office

This article was originally published in The Pink Sheet Daily

Executive Summary

The Division of Drug, Advertising, Marketing and Communications will consist of an office with two divisions, one to review materials for healthcare professionals and other to review direct-to-consumer promotions.

You may also be interested in...



FDA’s Promotional Assessments Reorganized Around Specialty, Not Target Audience

The two divisions within the Office of Prescription Drug Promotion are renamed the divisions of advertising and promotion review I and II; they will each have four teams operating within them in a structure akin to the Office of New Drugs.

FDA’s Rx Enforcement Letter Output Drops In 2011; OPDP Sees Improvement In Promotions

The 30 letters issued are the lowest since 2008, but FDA says the number is only part of its enforcement strategy.

DTC Pre-Review Guidance In The Works For Rx TV Ads, FDA’s Abrams Says

Certain drug classes will be required to submit certain types of ads, according to Tom Abrams, director of CDER’s recently elevated Office of Prescription Drug Promotion, but specifics will await the guidance itself.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS070274

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel